Little DD heads up for everyone on here. Nugget I found. If you scroll through the CVS website; it will give you hyperlinks to all there offerings except one.. which iis "mind Companion" = that launches on Jan 1. That is DarioHealths platform / ticker DRIO. They put it on there website in anticipation of there launch. Loading up before the Jan announcement. Should add above 35M in revenue at peak numbers. https://www.cvshealth.com/services/health-care-and-wellness/mental-health/resources-for-living/navigating-mental-health.html

https://www.sec.gov/Archives/edgar/data/1533998/000110465923109608/tm2328573d1_ex99-1.htm investor day deck review $DRIO health. Was a super-positive day all around...

Join us on October 17th at 11am ET for the

@dariohealth ( $DRIO) Investor Day, featuring industry experts, discussing the rise of digital health and DarioHealth’s multi-chronic condition platform. Register here: http://brnw.ch/21wDeV3

Two tickers I traditionally play that have gotten great news. Gritstone in upwards to 432 million in barda money and American Resources on its second bid of over 200+million for there Carbon Business. Both tickers are in the process of a reval as a result with no one watching. I still believe both have plenty of more room to run. If you look at my track record on here, I believe every play I have posted on here have paid off very well. Enjoy...

https://commonstock.com/post/23a0a86c-046b-4b71-b009-8ec3cfefece4 by @michael82929

https://commonstock.com/post/6ba65cb8-8540-4053-af12-0e41becd3ecc by @michael82929

CRVS - calling on one of my historical trade tickers for a money trade. I have always made money on this ticker heading into events (earnings May / readout June/July). Took a position in the mid 70s about a month ago. Since then, they've terminated their ATM with Jefferies, CEO took a huge pay cut and took options and as of last week became Nasdaq compliant. Technicals have finally caught up and haven't had a cross since 2021. Supported by some serious hedge players and when they balloon this up .. they typically do it with both barrels. I am definitely pulling out my palms palms here so take it for face value.. Do the DD yourself and if you see if this is a low risk / nice reward trade, do as you wish.

With the recent $TDOC news and Blackstone news this AM... DTX plays (which are grossly oversold) - may see a value cycle ($TDOC $DRIO $AMWL $HIMS)

I am well connected in the digital space from my Livongo, Teladoc and Ontrak days. I have all been very bullish on Dario Health. And while the stock price hasn't performed (mostly due to Teladoc desimating the sector) and coming out of the pandemic, one thing I know is digital healthcare is the next frontier. Either in pharma, tech or the sector itself.

Eitan was the curator of the Livongo platform. It was his innovation that really put the pieces together for Livongo and make the platform so attractive. For Eitan to come to Dario speaks volumes to the potential of what lies ahead.

IMO, over the last yr, $DRIO has inked some of the best names, best sponsors, and its execution has made this an attractive buy at these levels. IMO, this has no business sitting at 100mc and literally should be in the 300-400M MC today. Don't sleep on this ticker.

And for sprinkles on this ice cream, Arnaud Robert was a former C-Suite at Sanofi (Dario's current sponsor/partner) and also believe that isnt a coincidence. This year, Sanofi brought Prevention for over 1B and if Dario continues to deliver, it wouldn't surprise me if Dario is bolted into the mother ship sometime down the road. While Dario/Sanofi current have a 30m strategic in place from last yr, Sanofi has spent over 100m internally building there digital therapeutics arena leveraging Dario as the KOL.

Uncut Gem - $SURG (started a position - anything under 4.50 is gravy) - this caught my attention after the Mint Mobile acquisition over the last couple weeks.

This company has a lot of potential. Playing a small fish in a big pond with ACP. Finally, is doing all the work that no one wants to put the effort into. Underbanked community. However, once successful, I think someone will see what I see and want to take them out.

OVERVIEW

 SurgePays recently (on March 30) reported its fiscal Q4 2022 (ending December) results.

 Revenue was $36 million (+156% y-o-y), compared to our estimates of $45 million and consensus of $43 million.

 EPS was $0.23, compared to our estimates of $(0.04) and consensus of $(0.01).

 Q4 revenue guidance was $45 million. In early March, the company had preannounced Q4 revenues of $35 - 36 million.

 The company provided initial 2023 guidance for revenue of “at least” $190 million (+56%).

 We are adjusting our 2023 estimates for revenue to $190 million, from $200 million, and for EPS to $0.40 from $0.12.

 We are initiating our 2024 estimates for revenue of $228 million, and for EPS of $0.67.

ADDITIONAL DETAILS

 Gross profit for the quarter was $6.7 million, compared with our estimate of $2.2 million.

 Gross margin for the quarter was 19%, versus our expectation of 5% and 13% last year.

 Operating expenses were $3.2 million, versus our expectation of $2.7 million.

 Operating income was $3.5 million, versus our expectation of a loss of $0.4 million.

 Net income was $3.0 million, versus our expectation of a loss of $0.4 million.

 In November 2021, the company’s stock was uplisted to the Nasdaq Capital Market (from OTCQB).

 In November 2021, the company effected a 1-for-50 reverse stock split.

 In February 2021, the company filed a Form S-1 registration statement with the SEC for the planned sale of ~25% of LogicsIQ

shares to the public (IPO). LogicsIQ will remain a majority-owned subsidiary of SurgePays. The exact details and timing of the

spinoff/IPO, capital structure, and management teams will be determined later.

 In April 2022, the company announced the acquisition of Torch Wireless, a provider of wireless broadband with the FCC’s

Affordable Connectivity Program (ACP) in a cash and limited royalties deal. The purchase price was ~$800,000.

The company’s balance sheet had $7 million in cash and $8 million in debt, compared with $8 million in cash and $13 million in debt

at the end of September. In November, the company announced a new $25 million credit line